Indeks Tulisan

Ping An Group Upgrades Longevity Management Service System, Unveils 11 Health Longevity Centers Nationwide
SHANGHAI, July 30, 2026 /PRNewswire/ -- Ping An Insurance (Group) Company of China, Ltd. ("Ping An Group") held a service upgrade press conference yesterday themed "Professionalism Safeguards a Century of Wellbeing", officially upgrading its "Ping An Health Longevity Management Service System". Rely

MetaOptics and Elsoft partner to scale next-generation semiconductor optics manufacturing equipment
SINGAPORE and GEORGE TOWN, Malaysia, July 30, 2026 /PRNewswire/ -- MetaOptics Ltd (Catalist: 9MT) ("MetaOptics" or the "Company", and together with its subsidiaries, the "Group") and Elsoft Research Berhad (Bursa Malaysia: 0090) ("Elsoft") today jointly announced a strategic partnership to co-develo

Netcore berganti nama menjadi Netcore.ai dan menjadi platform pemasaran berbasis AI agen pertama yang turut bertanggung jawab atas pertumbuhan pelanggan
Perubahan merek ini menandakan perubahan struktur: dari penyedia perangkat lunak menjadi mitra berbasis AI yang berfokus pada pencapaian hasil dan didukung oleh tujuh agen AI otonom maupun model kepemilikan bersama antara manusia dan AI KUALA LUMPUR, Malaysia, 30 Juli, 2026 /PRNewswire/ -- Netcore C

IBM and Qedma Demonstrate Quantum Advantage, Modeling Physics Beyond Classical Capabilities Through Trusted Quantum Computation
Qedma's quantum error reduction software, running on IBM quantum computers and tested against RIKEN and BlueQubit's supercomputing resources, has accurately resolved the dynamics of quantum materials unseen in classical simulation. YORKTOWN HEIGHTS, N.Y. and TEL AVIV, Israel, July 30, 2026 /PRNewswi

Robo.ai Appoints Former INTERPOL President H.E. Dr. Ahmed Naser Al-Raisi as Chairman of Its Subsidiary Alif Holding
Headquartered in Abu Dhabi, the Group serves government, public-sector and enterprise customers across the Middle East and global markets ABU DHABI, UAE, July 30, 2026 /PRNewswire/ -- Robo.ai Inc. (NASDAQ: AIIO) (the "Company") today announced the appointment of H.E. Dr. Ahmed Naser Al-Raisi, former

Yiren Digital Releases 2025 ESG Report: Advancing Responsible AI and Sustainable Growth
BEIJING, July 30, 2026 /PRNewswire/ -- Yiren Digital Ltd. (NYSE: YRD) ("Yiren Digital" or the "Company"), a leading company specializing in financial technology and artificial intelligence innovation across multiple industries in China and global markets, today announced the publication of its 2025

Robo.ai Appoints Former INTERPOL President H.E. Dr. Ahmed Naser Al-Raisi as Chairman of Its Subsidiary Alif Holding
Headquartered in Abu Dhabi, the Group serves government, public-sector and enterprise customers across the Middle East and global markets ABU DHABI, UAE, July 30, 2026 /PRNewswire/ -- Robo.ai Inc. (NASDAQ: AIIO) (the "Company") today announced the appointment of H.E. Dr. Ahmed Naser Al-Raisi, former

TAL Education Group Announces Unaudited Financial Results for the First Fiscal Quarter Ended May 31, 2026
BEIJING, July 30, 2026 /PRNewswire/ -- TAL Education Group (NYSE: TAL) ("TAL" or the "Company"), a smart learning solutions provider in China, today announced its unaudited financial results for the first quarter of fiscal year 2027 ended May 31, 2026. Highlights for the First Quarter of Fiscal Year

Beijing Review: Young People from China and the U.S. Get an Inside Look at the Future of Robotics
BEIJING, July 30, 2026 /PRNewswire/ -- On July 21, a China-U.S. youth delegation visited the Robot World in Beijing E-Town, where they got a firsthand glimpse of the future of technology. In the Robot World, the delegates tried out a brain-controlled car race, and watched robots perform a range of c

NMPA Accepts New Indication Application for Sacituzumab Tirumotecan (sac-TMT) as First-Line Treatment for Advanced TNBC
CHENGDU, China, July 30, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that a new indication application of its trophoblast cell-surface antigen 2 (TROP2)-directed antibody drug conjugate (ADC) sacituzumab tirumotecan (sa
Masuk tirto.id







